METTL3‐mediated m6A modification of pri‐miR‐148a‐3p affects prostate cancer progression by regulating TXNIP

Li, Guoqiang / Liu, Junwen / Wang, Yinhuai et al. | Wiley | 2023

METTL3‐mediated m6A modification of EPPK1 to promote the development of esophageal cancer through regulating the PI3K/AKT pathway

Jia, Jun / Yu, Longhai | Wiley | 2024

DHPS‐Mediated Hypusination Regulates METTL3 Self‐m6A‐Methylation Modification to Promote Melanoma Proliferation and the Development of Novel Inhibitors

Guo, Jing‐si / Ma, Jian / Zhao, Xi‐he et al. | Wiley | 2024

DHPS‐Mediated Hypusination Regulates METTL3 Self‐m6A‐Methylation Modification to Promote Melanoma Proliferation and the Development of Novel Inhibitors

Guo, Jing‐si / Ma, Jian / Zhao, Xi‐he et al. | Wiley | 2024

LncRNA HCG18 promotes prostate cancer progression by regulating the miR-512-3p/HK-2 axis

Zhu, Yaru / Wang, Zhijing / Li, Haopeng et al. | Elsevier | 2024